Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials

Rui Sun, Mercedes Bustamante, Venkatesh Kumar Gurusamy, Mark Lebwohl, Alice B Gottlieb, Philip J Mease, Atul Deodhar, Weibin Bao, Meryl Mendelson, Brion Porter, Deepa Chand, Victor Dong.